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Abstract
Background: The human endometrium undergoes cyclical regeneration throughout a woman’s reproductive life. Ectopic
implantation of endometrial cells through retrograde menstruation gives rise to endometriotic lesions which affect
approximately 10% of reproductive-aged women. The high regenerative capacity of the human endometrium at eutopic
and ectopic sites suggests the existence of stem/progenitor cells and a unique angiogenic system. The objective of this
study was to isolate and characterize putative endometrial stem/progenitor cells and to address how they might be
involved in the physiology of endometrium.
Methodology/Principal Findings: We found that approximately 2% of the total cells obtained from human endometrium
displayed a side population (SP) phenotype, as determined by flow cytometric analysis of Hoechst-stained cells. The
endometrial SP (ESP) cells exhibited preferential expression of several endothelial cell markers compared to endometrial
main population (EMP) cells. A medium specific for endothelial cell culture enabled ESP cells to proliferate and differentiate
into various types of endometrial cells, including glandular epithelial, stromal and endothelial cells in vitro, whereas in the
same medium, EMP cells differentiated only into stromal cells. Furthermore, ESP cells, but not EMP cells, reconstituted
organized endometrial tissue with well-delineated glandular structures when transplanted under the kidney capsule of
severely immunodeficient mice. Notably, ESP cells generated endothelial cells that migrated into the mouse kidney
parenchyma and formed mature blood vessels. This potential for in vivo angiogenesis and endometrial cell regeneration
was more prominent in the ESP fraction than in the EMP fraction, as the latter mainly gave rise to stromal cells in vivo.
Conclusions/Significance: These results indicate that putative endometrial stem cells are highly enriched in the ESP cells.
These unique characteristics suggest that ESP cells might drive physiological endometrial regeneration and be involved in
the pathogenesis of endometriosis.
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Introduction
Human endometrium, which lines the uterine cavity, exhibits
unique properties of cyclical regeneration and tissue breakdown
under the influence of estrogen and progesterone throughout the
course of a woman’s reproductive life. Retrograde shedding and
ectopic implantation of menstrual endometrial cells and tissue
fragments give rise to endometriotic lesions outside of the uterus.
Endometrial cells prepared from the human endometrium are also
capable of reconstituting functional endometrium in xenograft
models of endometriosis [1]. When single cell suspensions of
endometrial cells are transplanted under the kidney capsule of
severely immunodeficient NOD/SCID/cc
null (NOG) mice [1], the
reconstructed ectopic endometrial tissues show menstrual cycle-
related morphological and functional changes repeatedly in
response to treatment with estrogen and progesterone [1]. These
unique properties reflect the remarkable capacity of human
endometrial cells for regeneration at eutopic and ectopic locations,
and suggest the existence of stem/progenitor cells as well as an
angiogenic system in the human endometrium. Indeed, it has been
postulated that the endometrium contains a pool of multipotent
stem cells within the deep basalis layer, capable of cyclically
producing progenitor cells that further differentiate into each
endometrial cell component [2,3].
Several groups have identified a number of endometrial cell
subpopulations as candidate endometrial stem/progenitor cells.
These include clonogenic endometrial cells [4], endometrial SP
cells which possess a Hoechst 33342 low-fluorescence profile [5,6],
CD146
+PDGFRb
+ stromal cells [7], and CD29
+CD73
+CD90
+
stromal cells [8]. The phenotypic and functional stem cell-like
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studies have yet explored the in vivo regenerative capacity of these
putative endometrial stem/progenitor cells. Candidate tissue-
specific stem cells have been identified in several tissues based
on the SP phenotype. This characteristic is due to the unique
ability of the primitive cells to pump out the DNA binding dye
Hoechst 33342 via the ATP-binding cassette transporter G2
(ABCG2) [9–12]. Primitive hematopoietic precursors from bone
marrow were the first SP cells identified with this technique [13].
We recently demonstrated that SP cells isolated from the human
uterine myometrium regenerate human myometrial tissues in vivo
when xenotransplanted into the uteri of NOG mice [14].
In the present study, we adapted our in vivo regeneration assay
and SP isolation procedure to characterize the properties of
human endometrial SP (ESP) cells. These cells were able to
differentiate into endometrium-like tissue and a variety of
endometrial cell components when xenotransplanted into NOG
mice. This is the first in vivo evidence in support of the existence of
stem/progenitor cells in the ESP.
Results
Isolation of ESP and endometrial main population (EMP)
cells from human cycling endometrium
We first dissociated human endometria mechanically and
enzymatically and purified epithelial-enriched and stromal-en-
riched fractions as previously described [1]. Procedures for
preparing these two fractions are summarized schematically in
Figure 1A. Both fractions were then stained with Hoechst dye and
subjected to flow cytometric analysis and cell sorting.
We found that each preparation contained a small subset of cells
in the SP fraction (Figure 1B). SP cells constituted 2.74160.443%
(mean 6 SEM, n=43) of the viable cells in the epithelial-enriched
fraction, whereas SP cells represented 3.09160.439% (mean 6
SEM, n=43) of the stromal-enriched preparation. The appear-
ance of the SP populations was blocked by 50 mM reserpine
(Figure 1B, insets), a general characteristic of SP cells [15]. Since it
was unclear which SP fraction contained the endometrial stem/
progenitor cells, we mixed the epithelial and stromal SP cells or
isolated SP cells from the mixture of the two fractions. We
designated the SP and main population (MP) cells derived from
both fractions as ESP and EMP, respectively. Endometrial
replicative population was designated as ERP (Figure 1B). The
ESP and EMP cells were then used for further experiments. The
ESP cells represented 2.83260.326% (mean 6 SEM, n=52) of
the total living endometrial cells (Figure 1B).
We next examined whether the proportion of ESP cells varied
across the menstrual cycle. As shown in Figure 1C, the proportion
of ESP cells to the EMP + ERP fraction was the highest at the
early proliferative phase, decreasing gradually until its nadir in the
late secretory phase. This may reflect an increase in the number of
EMP cells from menstruation towards the late secretory phase.
Figure 1. Isolation of ESP and EMP cells. (A) Summary of procedures for the preparation of epithelial-enriched and stromal-enriched fractions
and the mixture of both fractions from human cycling endometria. (B) Flow cytometric distribution of ESP cells, EMP cells, and the endometrial
replicative population (ERP) in each of the three fractions stained with Hoechst 33342 indicated in Figure S1. Addition of 50 mM reserpine resulted in
the disappearance of the ESP fraction (inset in each panel). (C) Proportion of ESP in the whole fraction dissociated from human endometria at
different phases of the menstrual cycle. * P,0.01 and ** P,0.00005, versus early proliferative phase. Each bar indicates the mean 6 SEM. n=48.
doi:10.1371/journal.pone.0010387.g001
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To investigate the stem cell-like regenerative capabilities of ESP
cells in vivo, we transplanted ESP cells under the kidney capsule of
ovariectomized NOG mice, after which they were treated with a
17b-estradiol (E2) pellet for eight to ten weeks. As was seen in the
endometrial regeneration model [1], ESP cells, but not EMP cells,
generated a cystic mass (Figure 2A) with delineated glandular and
stromal structures at the site of transplantation (Figure 2B).
However, the reconstitution efficiency was low in that the
reconstitution of epithelial and stromal endometrial-like tissues
was observed in 2 out of 24 xenotransplanted mice (Figure 2C).
No macroscopically identifiable masses were generated in the
remaining 22 mice transplanted with ESP cells; however,
histological and microscopic analyses of the transplantation sites
revealed the existence of three distinctive tissue subtypes within
this area. Immunofluorescence studies revealed that the newly
formed tissue, but not the mouse kidney, stained with human
vimentin (Vm) antibody (clone V9) (Figure 2C). As V9 can
recognize only human Vm (hVm), the new tissue was clearly of
human origin. These we designated as the ‘‘vascular endothelial
type’’, ‘‘migrating endothelial type’’ and ‘‘stromal type’’, based on
the dominant type of human-originated structures or cell
components present in the transplanted site (Figure 2C). In the
‘‘vascular endothelial type’’, vessel-like structures consisting of
hVm
+ cells were dominant, together with some hVm
+ cells
migrating into the mouse kidney parenchyma (Figure 2C). We
confirmed that most of the migratory hVm
+ cells were positive for
CD31 (Figure S1A). Furthermore, ESP-derived CD31
+ endothe-
lium was surrounded by a layer of ESP-derived smooth muscle
cells positive for a-smooth muscle actin (aSMA) (Figure 2D). In the
‘‘migrating endothelial type’’, migratory cells positive for both
hVm and CD31 were dominant in the interspaces of the murine
kidney parenchyma (Figure S1A). This type was frequently
accompanied by stromal cell layers but not by vessel-like
structures. These results collectively suggest that ESP cells have
the potential to differentiate into not only small capillary vessels
but also mature arteries and veins. The ‘‘stromal type’’ showed
layers of fibroblastic hVm
+ cells, which were also positive for an
endometrial stromal cell marker, CD13 (Figure S1B). Notably, the
heterogeneity of the regenerated tissue or cell components was
more evident in kidneys transplanted with ESP cells than in those
transplanted with EMP cells. This indicates that ESP cells may
have a broader differentiative capability than cells in the EMP
fraction (Figure 2C), as the latter mainly gave rise to stromal cells
in vivo.
The glandular structure of the well-organized tissue was positive
for cytokeratin (CK), an epithelial marker (Figure 2E). The
regenerated tissue also contained human CD31-positive endothe-
lial cells (Figure 2F). It is well known that the endometrial
progesterone receptor (PR) is upregulated by E2 stimulation. In
agreement, PR was expressed prominently in the E2-exposed
endometrial tissue (Figure 2G). These results collectively suggested
that ESP cells had the potential to regenerate functional
endometrium; however, the efficiency of this process was low
Figure 2. Recreation of the human endometrium and its components from ESP cells in immunodeficient mice. (A) The macroscopic
appearance of an ESP-initiated lesion (surrounded by white arrowheads) in the kidney of a NOD/SCID/cc
null (NOG) mouse treated with E2 pellets for
10 weeks. Bar, 1 mm. (B) H&E-stained section of the same lesion indicated in (A). A small box marks a region shown at a higher magnification in the
adjacent panel as indicated. Bars, 500 mm (left) and 100 mm (right). (C) H&E-stained and immunofluorescence images of ESP- or EMP-initiated lesions
co-stained with DAPI and antibodies against CK and Vm where various endometrial cell components were formed. The right table shows the number
and frequency of the ESP- or EMP- initiated mice which predominantly possessed human endometrium with glandular structures, vessel-like
structures consisting of endothelial cells, migrating endothelial cells, or stromal cell components. Bars, 500 mm. (D) Immunofluorescence images of
serial sections of the ESP-initiated lesion co-stained with DAPI and antibodies against aSMA and hCD31. Note that ESP-initiated vessel-like structures
positive for hCD31 and Vm were surrounded by muscle-like layers positive for aSMA and Vm. Bars, 100 mm. (E) Immunofluorescence images of the
same lesion as (A) co-stained with DAPI and antibodies against CK and vimentin (Vm). Bars, 500 mm. The borders between the reconstituted tissue
and the mouse kidney (MK) are indicated by the dotted lines. (F) Immunofluorescence images of the ESP-initiated lesion co-stained with DAPI and
antibodies against human CD31 (hCD31) and Vm in NOG mice. Yellow arrowheads indicate hCD31-positive cells. Bars, 200 mm. (G)
Immunofluorescence images of the ESP-initiated lesion co-stained with DAPI and antibodies against PR and Vm. Bars, 50 mm.
doi:10.1371/journal.pone.0010387.g002
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ESP, only two mice displayed reconstitution of endometrium-like
tissue with a glandular structure, which we designated as
‘‘glandular type’’ (Figure 2C).
Growth and differentiation potentials of ESP and EMP
cells
To further characterize ESP cells in vitro, we attempted to
cultivate and expand the cells using conventional media
supplemented with various hormones and/or growth factors;
however, ESP cells alone never proliferated efficiently. Further-
more, while SP cells derived from human myometrium are able to
proliferate preferentially under hypoxic condition [14], ESP cells
were not. When cultured together, however, ESP and EMP cells
readily proliferated in vitro in conventional media (Figure 3A),
suggesting that cell-to-cell interactions and/or EMP cell-derived
secretory factors may be a prerequisite for the activation of ESP
cells.
In vivo migratory and angiogenic potentials of freshly isolated
ESP cells (Figure 2C, 2D, and S1) suggest that they may have
endothelial cell (EC)-like properties. Therefore, we tested several
media customized for EC culture and finally found that ESP cells
were able to proliferate in EGM-2MV in the absence of EMP
(Figure 3B and 3C).
A clonogenic assay using EGM-2MV medium revealed that the
cloning efficiency of ESP cells (0.14360.008% [mean 6 SEM,
n=5]) was significantly less than that of EMP cells
(0.51160.054% [mean 6 SEM, n=4])(Figure 3B). It has been
reported that SP cells isolated from the human endometrium,
myometrium and other types of tissues are in the G0 phase of the
cell cycle [6,14,16,17]. Given the quiescence of ESP cells
[6,14,16,17], it is conceivable that our clonogenic assay using
short-term (14 days) culture may detect the clonogenic activities of
committed progenitors (perhaps stromal progenitors) in EMP cells,
but not those of the endometrial stem cells and/or the most
primitive progenitors in ESP cells. Elucidation of the precise
mechanism(s) awaits further studies.
Immunofluorescence studies revealed three distinct types of
colonies in the ESP cultures. The most frequent type was
comprised of fibroblastoid stromal cells positive for CD13, an
endometrial stromal cell marker (Figure 3C). The second most
frequent type displayed a cobblestone appearance and was
comprised of CD31-positive cells (Figure 3C), which indicated
similarities between these cells and late outgrowing endothelial
progenitor cells (EPCs) [18]. The least frequent type of colony
formed small nests that were comprised of epithelial cells positive
for CK, an endometrial epithelial marker (Figure 3C). In contrast
to ESP cultures, most of the colonies in the EMP cultures were
comprised of CD13-positive fibroblastic stromal cells (Figure 3C).
Therefore, ESP cells and not EMP cells possessed the stem/
progenitor cell characteristic of generating many lineages of cell
types within the tissue in which they are located.
Subpopulations of ESP cells and their morphology,
surface markers, and localization in the human
endometrium
To further characterize ESP cells, gene expression analysis of
ESP and EMP cells was performed using RT-PCR. ESP cells
preferentially expressed mRNA of universally SP-associated
markers, ABCG2 and multidrug resistance 1 [15,19]. ESP cells
also expressed CD31, CD34 and KDR (Figure 4A), consistent
with the EC-like properties of ESP cells. Interestingly, estrogen
receptor (ER) b was abundant in ESP, while neither ERa nor PR
was detected. ERb is also preferentially expressed in the vascular
endothelial cells of the human endometrium [20]. The expression
of these markers in ESP cells did not change after two weeks of
culture (Figure 4A), except for a slight increase and decrease in
ERa and ERb mRNA expression, respectively. This indicates that
EGM-2MV medium has the potential to maintain the undiffer-
entiated status of ESP.
Flow cytometric analysis of ESP cells from whole endometrium
stained with CD31, CD34, and CD144 antibodies, revealing that
ESP cells preferentially expressed these EC-associated markers
(Figure 4B). Thus, the expression pattern of the surface markers,
the cobblestone-like cell morphology in EGM-2MV medium and
the in vivo capacity to preferentially give rise to ECs (Figure 3C, 3D
and 3F) are all properties of ESP cells that are shared with EC or
EPC. In terms of hematopoietic or mesenchymal stem cell
markers, our flow cytometric data showed that some SP cells
express CD34, CD90, CD105 or CD146, but do not CD133
(Figure S2), and ESP is not a homogeneous population.
Since ESP cells, like other SP cells, expressed the SP-specific
marker ABCG2 [15], we performed immunofluorescence staining
of human cycling endometrium using ABCG2 antibody to address
Figure 3. Growth and differentiation potentials of ESP and EMP cells. (A) Fluorescence images of DiI-labeled ESP cells co-cultured with DiO-
labeled EMP cells following Hoechst DNA dye staining. Bars, 200 mm. (B) Cloning efficiencies of ESP cells and EMP cells in EGM-2MV medium.
* P,0.001. Each bar indicates the mean 6 SEM. N $4. (C) Phase contrast micrographs and fluorescence images (insets) of colonies generated from
ESP and EMP cultures. The ESP cells and EMP cells were separately seeded at a clonal density, cultured in EGM-2MV medium for two weeks, and
subjected to immunofluorescence studies using antibodies against the indicated markers. CK, cytokeratin. Bars, 500 mm.
doi:10.1371/journal.pone.0010387.g003
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stem/progenitor cells are believed to reside in the basalis layer of
the human endometrium. Given that the ESP contains candidate
endometrial stem/progenitor cells, we anticipated ABCG2
+ cells
might be predominantly located in the basalis layer. Unexpectedly,
however, ABCG2
+ cells were evenly distributed across both the
functionalis and basalis layers of the endometrium (Figure 4C).
Taking into account the expression of CD31 in the ESP, we
performed double immunofluorescence staining using CD31 and
ABCG2 antibodies to examine the localization of CD31
+ ESP cells
in human cycling endometrium. We found that CD31
+ABCG2
+
cells, presumably containing CD31
+ ESP cells, were preferentially
located in small capillaries, rather than large vessels (Figure 4D).
Again, CD31
+ABCG2
+ cells were present throughout the
functionalis and basalis layers.
Discussion
Human and primate endometrium regenerates from the lower
basalis layer, a germinal compartment that persists after menstru-
ation to give rise to the new upper functionalis layer [2,21–23]. The
surface epithelium develops primarily through the proliferation of
epithelial cells from the tips of the gland stumps [24,25]. The
findings presented here strongly support the idea that the basalis of
the endometrium harbors stem/progenitor cells responsible for
endometrial regeneration during menses as well as after parturi-
tion in both women and menstruating non-human primates [23].
It remains possible, however, that endometrial stem/progenitor
cells also exist in the functionalis of the endometrium. Indeed, the
ABCG2
+ population, which presumably includes ESP cells having
endometrial stem cell-like properties (present study and [5]), is
localized exclusively in the endothelium of both the functional and
basal layers of the human endometrium (Figure 3 and [6]). A
relatively small number of dispersed human endometrial cells
(mainly derived from the functionalis layer of the endometrium)
containing ESP cells can generate functional endometrial tissue
comprising glands, stroma, immune cells and vascular components
when they are transplanted under the kidney capsule of severely
immunodeficient mice [1]. Mesenchymal stem-like cells expressing
both CD146 and PDGF-Rb are located perivascularly in the
functionalis and basalis layers of the human endometrium [7]. Very
recently, Garry et al. demonstrated that endometrial surface
epithelial regeneration takes place as a consequence of cellular
differentiation from stromal cells and not by direct extension from
the residual basal epithelial glands [26]. These findings collectively
suggest that ESP cells present in the vascular endothelium are one
of the most likely candidates for endometrial stem/progenitor cells
that may reside not only in the basalis but also in the functionalis
endometrium.
The percentage of SP cells derived from cultured epithelial-
enriched fraction was significantly greater during menstruation
than at any other cycle stage [5], whereas the rate of SP cells
freshly isolated from endometrial samples was significantly greater
in the proliferative phase than in the secretory phase [6]. In this
study we showed that the proportion of ESP cells to the EMP +
ERP fraction freshly isolated from human endometria was the
highest at the early proliferative phase among all the phases of the
menstrual cycle, which is in agreement with previous report [6],
and it decreased gradually until its nadir in the late secretory
phase. Given the stem cell-like properties of ESP cells as presented
Figure 4. Subpopulations of ESP cells: surface markers, and localization in human endometrium. (A) RT-PCR analyses of various
transcripts in ESP and EMP cells before and after two weeks of culture. MDR1, multidrug resistance 1; KDR, kinase insert domain-containing receptor.
(B) Flow cytometric analysis of ESP and EMP cells immunostained with isotypic control antibodies or antibodies against endothelial cell surface
markers (CD31, CD34, and CD144). (C) An immunofluorescence merged image of human endometrium co-stained with Hoechst and antibodies
against ABCG2 and aSMA. White and yellow dotted lines indicate the endometrium-myometrium junction and the luminal surface of the uterine
epithelium, respectively. Bars, 200 mm. (D) Immunofluorescence images of human endometrium co-stained with Hoechst and antibodies against
hCD31 and ABCG2. A small box marks a region shown at a higher magnification in the adjacent panel as indicated. Yellow arrowheads indicate
endothelial cells doubly positive for hCD31 and ABCG2. Bars, 200 mm (upper), 100 mm (lower left) and 50 mm (lower right).
doi:10.1371/journal.pone.0010387.g004
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ESP cells may generate committed progenitor cells through
asymmetrical cell division, which, in turn, may lose the SP
phenotype, further behave as transient amplifying cells, and
eventually propagate through symmetrical cell division. In this
context, the gross number of ESP cells may be almost unchanged,
but the number of non-SP cells (EMP + ERP cells) present
particularly in the functionalis endometrium may increase, presum-
ably resulting in the decline in the proportion of ESP cells from
menstruation towards the late secretory phase.
There are several explanations for the low efficiency of
reconstitution. First, the local environment at the xenotransplan-
tation site may lack necessary factors for the regeneration of the
entire endometrium. Second, ESP cells may require a specific
‘‘niche’’ provided by other endometrial cell components to
reconstitute the entire endometrium in vivo as well as in vitro
culture. Successful proliferation of ESP cells in the presence of
EMP cells in conventional media (Figure 3A) suggests that EMP
cells may provide a ‘‘niche’’ appropriate for activation of ESP cells.
Moreover, successful proliferation of ESP cells alone in EGM-
2MV medium prompts us to postulate that EMP cells alone and/
or cell-to-cell interaction between ESP and EMP cells may
produce bioactive substances such as EGF, VEGF, bFGF, and/or
insulin-like growth factor-I that EGM-2MV medium contains.
Microenvironments under the kidney capsule of NOG mice may
also provide some but not sufficient ‘‘niche’’, which may be at least
in part attributed to low efficiency of reconstitution of organized
endometrial tissue from ESP cells. We have previously demon-
strated that the single cell suspension without any cell selection
which consisted of ESP cells and non-SP cells could reconstitute
well-organized endometrial tissue at almost 100% frequency [1],
which is much greater than the rate of ESP cells alone (8%). These
findings suggest that EMP cells are required as a ‘‘niche’’ provider
for in vivo tissue reconstitution but EMP cells alone may not be able
to generate the organized endometrial tissues in vivo. Third, ESP
cells might not contain a sufficient number of stem/progenitor
cells for generating glandular cells. In this study, we collected
endometrial tissues by scraping strongly the uterine cavity with the
back edge of a scalpel. A portion of the endometrium, particularly
the deep basalis layer, however, penetrates into the myometrium
where it will not be collected by scraping (Figure S3). Thus, it is
possible that some of the ESP cells present in the deep basalis layer
may not be included in the starting endometrial materials in this
study.
In this study, we have shown that at least some ESP cells were
localized to the endometrial endothelial wall, predominantly
expressed several EC markers, preferentially proliferated and
differentiated in vitro in an EC-specific medium, and displayed high
migratory and angiogenic potential. These results suggest that ESP
cells have endometrial stem cell-like properties as well as EC or
EPC-like characteristics. EPCs are believed to be derived from the
bone marrow and to home to sites of neovascularization and
neoendothelialization where they differentiate into ECs [27,28].
This raises the possibility that ESP may have originated from bone
marrow stromal cells. Indeed, bone marrow-derived EPCs
contribute to the formation of new blood vessels in human and
mouse endometrium [29,30]. Furthermore, bone-marrow derived
cells give rise to uterine epithelial cells in humans [31] and mice
[32,33], although the identity of these cells remains unclear. Based
on the present results, we speculate that ESP represents one such
candidate population.
In view of these findings, we here propose a single model for
ESP-driven endometrial regeneration and establishment of
endometriosis (Figure 5). In this model, ESP cells, perhaps
ultimately derived from the bone marrow, mainly reside in
vascular endothelial walls and/or perivascular regions. Important-
ly, these ESP cells are present not only in the basalis but also in the
functionalis endometrium. These cells, therefore, might be con-
tained within the sloughed endometrium shed at menstruation.
They might then implant onto the surface of ectopic sites such as
the peritoneum through retrograde menstruation. Furthermore,
some of these functionalis layer-derived ESP cells might remain in
the uterine cavity after menstruation and implant again (reimplant)
onto the deconstructed eutopic endometrium. In both eutopic and
ectopic implantation, endothelial ESPs might give rise to various
endometrial cell components in the process of ESP-driven
angiogenesis. Our eutopic reimplantation hypothesis does not
contradict the current paradigm but rather provides an additional
mechanism for endometrial regeneration. We describe previously
that a certain type of cells in endometrium could migrate, invade,
form chimeric vasculature in the host kidney of NOG mouse and
establish the functional circulatory system[1]. In terms of the
ability to invade into kidney parenchyma, these cells could be SP
cells. From this point, their ability may be crucial for establishment
and development endometriosis, because the angiogenesis is
absolutely required for maintenance of endometriotic lesion. In
support of this idea, a stem cell theory of the pathogenesis of
endometriosis has been recently emerged [34], postulating that
endometrial stem/progenitor cells may function in the develop-
ment of endometriosis. Our proposed new model suggests that
only a small population of endometrial cells, specifically ESP cells,
has the potential to generate endometriotic lesions through their
unique migratory and angiogenic activities and provides a proving
ground of anti-angiogenic therapy recently proposed as a potential
treatment for endometriosis [35–37].
We have shown that ESP cells, but not EMP cells, express ERb
but do not express ERa or PR. A similar expression pattern is
observed in endometrial vascular ECs which express ERb, but
neither ERa nor PR [20]. Those findings further substantiate our
present results that ESP cells have EC-like properties and reside in
the endometrial endothelium. Finally, the expression level of ERb
is strikingly higher than those of ERa and PR in endometriotic
lesions [38], implicating ERb-positive ESP cells in the pathogen-
esis of endometriosis.
In summary, we have demonstrated that undifferentiated ESP
cells are present in human cycling endometrium. Purified ESP
cells, but not EMP cells, contain putative endometrial stem/
Figure 5. Proposed model for ESP-driven endometrial
regeneration and the establishment and progression of
endometriosis.
doi:10.1371/journal.pone.0010387.g005
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types of endometrial cells in vitro and in vivo. In our hands, ESP cells
were not able to proliferate from a single cell in vitro. Without single
cell analyses, it remains uncertain whether individual ESP cells
posses multi-lineage differentiation potential at the clonal level or,
instead, the cells consists of a mixed population of progenitors or
stem cells. The study of the ESP, however, will improve the
understanding of endometrial physiology and provide insight into
the pathogenesis and treatment of endometrium-derived diseases
such as endometriosis.
Materials and Methods
Detailed protocols can be found in Methods S1.
Tissue collection
Endometrial specimens (n=78) were collected from women
with normal menstrual cycles undergoing total abdominal
hysterectomy for benign gynecological diseases, or cervical
carcinoma in situ. Written informed consent was obtained from
each patient and the use of these human specimens was approved
by the Keio University Ethics Committee.
Isolation and flow cytometric analysis of ESP and EMP
cells
Endometrial specimens were separated and dissociated into
endometrial stromal and glandular epithelial single cell fractions as
described previously [1]. Stromal-enriched and epithelial-enriched
fractions were washed in calcium- and magnesium-free HBSS
supplemented with 2% FBS, 10 mM HEPES buffer, and 1%
penicillin-streptomycin (HBSS
+) and suspended at 2610
6 cells/
mL in HBSS
+ and stained with 5.0 mg/mL Hoechst33342 (Sigma
Chemical, St. Louis, MO) for 90 min at 37uC, as described
previously [12,13]. Fluorescein isothiocyanate, phycoerythrin or
allophycocyanin-conjugated antibodies for flow cytometry and
propidium iodide were simultaneously added to Hoechst-stained
cells suspended in HBSS
+. Cells were incubated on ice for 30
minutes, pelleted, and washed with HBSS
+. The antibodies we
used are listed in Table S1. Flow cytometric analysis and cell
sorting were performed as described in SI Methods. After collecting
1610
5 events, the SP population was defined as previously
reported [13].
Co-culture of SP and MP cells
To track the fate of SP cells in co-culture with MP cells, the
SP and MP cells were labeled with two different fluorescent
dyes-Vybrant DiO (green fluorochrome) and Vybrant DiI (red
fluorochrome) (Molecular Probes, Eugene, OR). These reagents
allow two-color labeling of cell populations for identification
after mixing and co-culture. DiI-labeled SP cells and DiO-
labeled MP cells were mixed at a ratio of 1:1 and co-cultured
in DMEM containing 1% antibiotic-antimycotic, and 10%
FBS.
Cell culture and determination of cloning efficiency
SP and MP cells were separately seeded at a clonal density of
400 cells/cm
2 in 35 mm dishes and cultured in EGM-2MV
medium (Cambrex, Walkersville, MD). After 14 days of culture,
clusters of cells were considered colonies when they were visible
macroscopically and had more than 50 cells. Colonies were
counted and the cloning efficiency (CE) was determined from the
formula: CE (%) = (number of colonies/number of cells seeded)
6100.
RT-PCR
Total RNA was extracted from cell cultures and subjected to
RT-PCR. First-strand cDNA was synthesized and amplified using
specific PCR primers (Table S2). The PCR products were
separated by electrophoresis on agarose gels and visualized by
ethidium bromide staining with UV light illumination.
Xenotransplantation and hormonal treatment
The same numbers of SP and MP cells (10
4 to 10
5 cells), freshly
isolated from human endometria, were immediately transplanted
under the kidney capsules of NOG mice as described previously
[1].
Histology and immunohistochemistry
H&E-staining and immunofluorescence analyses were per-
formed on culture dishes or cryosections derived from kidneys
transplanted with ESP or EMP, that were air-dried, washed, and
fixed. After permeabilization and blocking, tissue sections were
incubated with the pretitrated primary antibodies listed in Tables
S1 and S3. For indirect fluorescence staining, the first antibodies
were visualized by incubation with secondary antibodies conju-
gated with Alexa Fluor 488 (green) or 568 (red) (Molecular
Probes). We classified the histological feature of the reconstituted
tissue and its adjacent transplantation site into four subtypes (i.e.,
glandular, vascular endothelial, migrating endothelial, and stro-
mal), based on their dominant type (Figure 2C). The reconstitution
rate of ESP and EMP cells was determined by the following
formula: Reconstitution rate (%) = (number of a corresponding
subtype/number of transplanted kidneys) 6100. Images were
collected as described in SI Methods.
Statistics
Results are expressed as means 6 SEM. Comparisons among
the SP rates for each of the four phases were made with a Tukey
test and the others were done using the unpaired Student’s t test. P
values less than 0.05 were considered statistically significant.
Supporting Information
Figure S1 Expression of endothelial and stromal cell markers in
human-derived cells present around the ESP-initiated lesion.
Immunofluorescence images of the ESP-initiated lesion in NOG
mouse kidney co-stained with DAPI and antibodies against Vm and
hCD31 (A) or antibodies against Vm and CD13 (B). Bars, 100 mm.
Found at: doi:10.1371/journal.pone.0010387.s001 (4.16 MB TIF)
Figure S2 Expression of hematopoietic stem cell marker and
mesenchymal stem cell marker on ESP cells. Flow cytometric
analysis of ESP cells stained with antibodies against hematopoietic
stem cell markers (CD34 and CD133) and mesenchymal stem cell
markers (CD90, CD105 and CD146).
Found at: doi:10.1371/journal.pone.0010387.s002 (3.15 MB TIF)
Figure S3 Remaining basalis layer of endometrium after
endometrial tissue has been scraped off. Histological and
immunofluorescence images of the uterine interface between the
endometrium and myometrium stained with H&E or antibodies
against CK and aSMA. Bars, 500 mm. Black and yellow
arrowheads indicate endometrial glands present adjacent to or
inside the myometrium.
Found at: doi:10.1371/journal.pone.0010387.s003 (0.96 MB TIF)
Table S1 List of antibodies used for flow cytometric analysis.
Found at: doi:10.1371/journal.pone.0010387.s004 (0.03 MB
DOC)
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PLoS ONE | www.plosone.org 7 April 2010 | Volume 5 | Issue 4 | e10387Table S2 Sequences of the primers used for detection of various
genes.
Found at: doi:10.1371/journal.pone.0010387.s005 (0.04 MB
DOC)
Table S3 List of antibodies used for immunofluorescence
staining.
Found at: doi:10.1371/journal.pone.0010387.s006 (0.04 MB
DOC)
Methods S1
Found at: doi:10.1371/journal.pone.0010387.s007 (0.07 MB
DOC)
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